Seroprevalence of SARS-CoV-2 infection and associated factors among Bangladeshi slum and non-slum dwellers in pre-COVID-19 vaccination era: October 2020 to February 2021

• Published in: PloS one 2022-05, Vol.17 (5), p.e0268093-e0268093
• Main Authors: Raqib, Rubhana, Sarker, Protim, Akhtar, Evana, Nurul Huda, Tarique Mohammad, Haq, Md Ahsanul, Roy, Anjan Kumar, Hosen, Md Biplob, Haque, Farjana, Chowdhury, Md Razib, Reidpath, Daniel D, Emdadul Hoque, Dewan Md, Islam, Zahirul, Ahmed, Shehlina, Ahmed, Tahmeed, Tofail, Fahmida, Razzaque, Abdur
• Format: Article
• Language: English
• Subjects: Adult; Antibodies, Viral; Asymptomatic; Asymptomatic infection; Bangladesh - epidemiology; Biology and life sciences; Blood pressure; Body weight; Cardiovascular diseases; Child; Chronic conditions; Chronic illnesses; Confidence intervals; Coronary artery disease; Coronaviruses; COVID-19; COVID-19 - epidemiology; COVID-19 - prevention & control; COVID-19 Vaccines; Cross-Sectional Studies; Data collection; Developing countries; Diabetes mellitus; Disease; Disease susceptibility; Earth Sciences; Education; Evaluation; Exercise; Ghettos; Heart diseases; Households; Humans; Hypertension; Immunization; Immunoassay; Income; Infections; LDCs; Low income groups; Masks; Medical supplies; Medicine and health sciences; Middle class; Mitigation; Overweight; Pandemics; People and Places; Population; Poverty Areas; Pressure measurement; Questionnaires; Respiratory diseases; Sample size; SARS-CoV-2; Seroepidemiologic Studies; Serology; Severe acute respiratory syndrome; Severe acute respiratory syndrome coronavirus 2; Slums; Social Sciences; Sociodemographics; Statistical analysis; Urban populations; Vaccination; Viral diseases; Washing
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0268093

Seroprevalence studies have been carried out in many developed and developing countries to evaluate ongoing and past infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Data on this infection in marginalized populations in urban slums are limited, which may offer crucial information to update prevention and mitigation policies and strategies. We aimed to determine the seroprevalence of SARS-CoV-2 infection and factors associated with seropositivity in slum and non-slum communities in two large cities in Bangladesh. A cross-sectional study was carried out among the target population in Dhaka and Chattogram cities between October 2020 and February 2021. Questionnaire-based data, anthropometric and blood pressure measurements and blood were obtained. SARS-CoV-2 serology was assessed by Roche Elecsys® Anti-SARS-CoV-2 immunoassay. Among the 3220 participants (2444 adults, ≥18 years; 776 children, 10-17 years), the overall weighted seroprevalence was 67.3% (95% confidence intervals (CI) = 65.2, 69.3) with 71.0% in slum (95% CI = 68.7, 72.2) and 62.2% in non-slum (95% CI = 58.5, 65.8). The weighted seroprevalence was 72.9% in Dhaka and 54.2% in Chattogram. Seroprevalence was positively associated with limited years of formal education (adjusted odds ratio [aOR] = 1.61; 95% CI = 1.43, 1.82), lower income (aOR = 1.23; 95% CI = 1.03, 1.46), overweight (aOR = 1.2835; 95% CI = 1.26, 1.97), diabetes (aOR = 1.67; 95% CI = 1.21, 2.32) and heart disease (aOR = 1.38; 95% CI = 1.03, 1.86). Contrarily, negative associations were found between seropositivity and regular wearing of masks and washing hands, and prior BCG vaccination. About 63% of the population had asymptomatic infection; only 33% slum and 49% non-slum population showed symptomatic infection. The estimated seroprevalence of SARS-CoV-2 was more prominent in impoverished informal settlements than in the adjacent middle-income non-slum areas. Additional factors associated with seropositivity included limited education, low income, overweight and pre-existing chronic conditions. Behavioral factors such as regular wearing of masks and washing hands were associated with lower probability of seropositivity.